Arcila, M. E., Drilon, A., Sylvester, B. E., Lovly, C. M., Borsu, L., Reva, B., . . . Ladanyi, M. (2014). MAP2K1 (MEK1) mutations define a distinct subset of lung adenocarcinoma associated with smoking. Clin Cancer Res.

Arcila, Maria E., Alexander Drilon, Brooke E. Sylvester, Christine M. Lovly, Laetitia Borsu, Boris Reva, Mark G. Kris, David B. Solit, and Marc Ladanyi. "MAP2K1 (MEK1) Mutations Define a Distinct Subset of Lung Adenocarcinoma Associated With Smoking." Clin Cancer Res 2014.

Arcila, Maria E., et al. "MAP2K1 (MEK1) Mutations Define a Distinct Subset of Lung Adenocarcinoma Associated With Smoking." Clin Cancer Res 2014.